inVentiv Health has extended its partnership with NeuroVive Pharmaceutical AB, a Swedish biotech firm specializing cardiovascular and neurological conditions, for development and commercialization services for NeuroVive’s lead product, CicloMulsion. inVentiv Health offers services from early-stage clinical development to full global commercialization, including drug development, risk management, market access and reimbursement, launch, marketing communications, payer relations and patient ...